immunity News and Research

RSS

Study examines psychological, social predictors of U.S. adults' willingness to get COVID-19 vaccine

The first COVID-19 vaccine has received emergency use authorization. Yet a key question remains: Will U.S. adults be willing to get it?

14 Dec 2020

New method shortens the timeline to generate mice for vaccine research

To develop vaccines and investigate human immune responses, scientists rely on a variety of animal models, including mice that can produce human antibodies through genetically engineered B cell receptors, which are specialized antibodies bound to the B cell membrane.

14 Dec 2020

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

The onslaught of the COVID-19 pandemic, the hunt for a drug, and the successful development of a vaccine has impacted people beyond measure worldwide.

14 Dec 2020

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

Researchers at the Hospices Civils de Lyon (HCL) in France found that people infected with SARS-CoV-2 can develop antibodies that persist for up to six months. After testing commercial assays to detect antibodies, the Wantai antibody assay has a positivity rate of 100%.

14 Dec 2020

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

A new study suggests an impact of the COVID-19 vaccine on SARS-CoV-2 attack rate, and hospitalizations, even with no protection against infection.

14 Dec 2020

Risk factors for COVID-19 vaccine acceptance

A recent study adds more evidence to the supposition that willingness to accept the COVID-19 vaccine depends on a variety of factors.

14 Dec 2020

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Researchers in the United States and Australia have conducted a comprehensive analysis of the epitope recognition patterns associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in humans.

14 Dec 2020

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Scientists have suggested that a proportion of the population have pre-existing immunity to COVID-19 because of T cells primed against SARS-CoV-2 antigens.

14 Dec 2020

Recovered COVID-19 patients exhibit persistent cellular immunity

Researchers at The Rockefeller University in New York have conducted a study showing that infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – triggers persistent T cell responses that last for at least six months.

14 Dec 2020

RNA editing within host linked to SARS-CoV-2 variants

Since the start of the COVID-19 pandemic, the causative virus, SARS-CoV-2, has undergone several mutations.

14 Dec 2020

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Cancer immunotherapy using "designer" immune cells has revolutionized cancer treatment in recent years. In this type of therapy, T cells, a type of white blood cell, are collected from a patient's blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) that is designed to enable T cells to recognize and destroy cancer cells.

14 Dec 2020

Study identifies protein as potential therapeutic target for leishmaniasis vaccines

According to the results of research led by the Complutense University of Madrid (UCM), one the various strategies deployed by the Leishmania parasite to avoid triggering the human immune system is to activate the SHP-1 protein.

11 Dec 2020

Healthy gut microbiota contributes to normal brain function, study shows

Depression is a mental disorder that affects more than 264 million people of all ages worldwide. Understanding its mechanisms is vital for the development of effective therapeutic strategies.

11 Dec 2020

Pre-existing immunity shapes a person's antibody response to influenza viruses

New research by scientists at the University of Chicago suggests a person's antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected.

11 Dec 2020

immunity News and Research

Study examines psychological, social predictors of U.S. adults' willingness to get COVID-19 vaccine

New method shortens the timeline to generate mice for vaccine research

AI-enabled real-time social-media monitoring of public sentiments on COVID-19 vaccination

Researchers test commercial assays to detect SARS-CoV-2 antibodies six months after infection

COVID-19 vaccination may potentially cut hospitalizations, deaths by 60% in Ontario, Canada

Risk factors for COVID-19 vaccine acceptance

Epitope “megapools” could help determine role T cell immunity plays in COVID-19

Prior T cell immunity to SARS-CoV-2 unlikely to be the result of seasonal coronavirus infection

Recovered COVID-19 patients exhibit persistent cellular immunity

RNA editing within host linked to SARS-CoV-2 variants

Study shows how STAT5 optimizes function of CD4+ T cells to drive antitumor immunity

Study identifies protein as potential therapeutic target for leishmaniasis vaccines

Healthy gut microbiota contributes to normal brain function, study shows

Pre-existing immunity shapes a person's antibody response to influenza viruses

Scientists use human stem cells and bioengineered scaffold to build whole functioning thymus

Reverse phenotyping shows reactive T cell profiles in SARS-CoV-2 infection

Single N primer sufficient for SARS-CoV-2 molecular diagnosis

EKF launches high performance quantitative COVID-SeroKlir antibody test kit

National lung health organizations urge universal vaccine adoption to end COVID-19 pandemic

Study provides a detailed understanding of the interplay between obesity and cancer

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News